4
Changes in Ownership
PHIBRO ANIMAL HEALTH CORP Filed Acc 0001104659-26-028472
President and CEO sold 5,280 shares at $48.91 ($258,245)
- President and CEO acquired 100,000 shares (conversion)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BENDHEIM JACK · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-12 | Conversion : show line 1 in the form 10b5-1 | +100,000 | 101,480 | I | ||
| 2026-03-13 | Sale : show line 2 in the form 10b5-1 | −5,280 | $48.91 | $258,245 | 96,200 | I |
| Open-market sales · 5,280 sh · avg $48.91 · $258,245 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-12 | Conversion : show line 3 in the form 10b5-1 Class B Common Stock | −100,000 | 19,596,034 | I |
Loading xslF345X05/tm268840-1_4seq1.xml…